AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 133 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $493,000 | +36.9% | 165,879 | -31.3% | 0.00% | 0.0% |
| Q2 2016 | $360,000 | -83.2% | 241,590 | -58.3% | 0.00% | -80.0% |
| Q1 2016 | $2,145,000 | -86.2% | 579,635 | -62.4% | 0.01% | -84.8% |
| Q4 2015 | $15,588,000 | -18.6% | 1,543,362 | +9.6% | 0.03% | -10.8% |
| Q3 2015 | $19,154,000 | -32.8% | 1,408,396 | -6.3% | 0.04% | -31.5% |
| Q2 2015 | $28,501,000 | -0.7% | 1,502,443 | +37.1% | 0.05% | +1.9% |
| Q1 2015 | $28,689,000 | -10.3% | 1,096,237 | -28.3% | 0.05% | -22.1% |
| Q4 2014 | $31,993,000 | +382.2% | 1,527,857 | +668.7% | 0.07% | +300.0% |
| Q3 2014 | $6,635,000 | -33.9% | 198,758 | -36.5% | 0.02% | -39.3% |
| Q2 2014 | $10,041,000 | +2.8% | 312,892 | +47.9% | 0.03% | 0.0% |
| Q1 2014 | $9,772,000 | +12.1% | 211,597 | +72.2% | 0.03% | 0.0% |
| Q4 2013 | $8,721,000 | -41.1% | 122,906 | -28.9% | 0.03% | -41.7% |
| Q3 2013 | $14,819,000 | -25.5% | 172,815 | -45.0% | 0.05% | -21.3% |
| Q2 2013 | $19,898,000 | – | 314,142 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 537,034 | $38,108,000 | 6.25% |
| ADVENT INTERNATIONAL, L.P. | 547,001 | $38,815,000 | 4.56% |
| Perceptive Advisors | 447,785 | $31,775,000 | 3.82% |
| HealthCor Management, L.P. | 850,000 | $60,316,000 | 3.66% |
| Rhenman & Partners Asset Management AB | 75,000 | $5,322,000 | 2.08% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 580,000 | $41,157,000 | 1.89% |
| ISZO CAPITAL LP | 33,150 | $2,352,000 | 1.74% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 458,410 | $32,501,000 | 1.49% |
| Cupps Capital Management, LLC | 277,097 | $19,662,000 | 1.34% |
| CABOT WEALTH MANAGEMENT INC | 61,987 | $4,399,000 | 1.15% |